Medtech veteran Dave Johnson has been with Alliqua Biomedical for less than 2 years, during which time he's overseen a major hiring spree, 3 business development deals and the company's 1st acquisition. In an interview with MassDevice.com, Johnson talks about his step-by-step perspective and where he hopes Alliqua will be in 5 years.
Boston Millennia's managing general partner Dana Callow discusses the 11-year journey to bring CardioMEMs implantable heart monitor to market and what his venture capital firm sees for the future of medtech investment.
The Emergo Group Blog provides short updates on quality and regulatory topics that may be of interest to QA/RA professionals in the medical device and IVD industry. No fluff, just straight to the point. We hope you'll enjoy the content.
The French Ministry of Health offers to provide financial support to treat 36 patients with Second Sight Medical's Argus II retinal prosthesis system.
Second Sight Medical announced this week that it landed a financial contract with the French Ministry of Health to provide funding for the 1st wave of patients in the country to receive treatment with the Argus II vision system.
Opponents of the medical device tax have new grounds for their calls for repeal after a U.S. Treasury report finds that the IRS is having a hard time making sense of the levy.
MASSDEVICE ON CALL — Medical device industry lobbyists have new ammunition in the fight against the 2.3% Affordable Care Act tax thanks to a U.S. Treasury report citing several issues with the IRS's management of the levy.
Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com's coverage highlights our 3 biggest and most influential stories from the day's news to make sure you're up to date on the headlines that continue to shape the medical device industry.